Neurocrine Biosciences Inc (NBIX) — Net Asset Quality Index
Neurocrine Biosciences Inc (NBIX) has a Net Asset Quality Index of 70.2% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $4.63 Billion minus total liabilities of $1.38 Billion yields net assets of $3.25 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read NBIX total debt and obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Neurocrine Biosciences Inc Net Asset Quality Index Over Time (1996–2025)
This chart shows how Neurocrine Biosciences Inc's Net Asset Quality Index has evolved across 30 annual periods from 1996 to 2025. As of December 2025, the index stands at 70.2%, representing net assets of $3.25 Billion against total assets of $4.63 Billion USD. For live market cap and overall valuation, see Neurocrine Biosciences Inc market capitalisation.
Annual Net Asset Quality Index for Neurocrine Biosciences Inc (1996–2025)
The table below presents the year-by-year Net Asset Quality Index for Neurocrine Biosciences Inc from 1996 to 2025, covering 30 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Neurocrine Biosciences Inc (NBIX) strategic investment index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 70.2% | $3.25 Billion | $4.63 Billion | $1.38 Billion | ▲ +0.6 pp |
| 2024 | 69.6% | $2.59 Billion | $3.72 Billion | $1.13 Billion | ▲ +1.0 pp |
| 2023 | 68.6% | $2.23 Billion | $3.25 Billion | $1.02 Billion | ▼ -3.5 pp |
| 2022 | 72.1% | $1.71 Billion | $2.37 Billion | $660.90 Million | ▲ +5.8 pp |
| 2021 | 66.3% | $1.37 Billion | $2.07 Billion | $698.50 Million | ▲ +1.4 pp |
| 2020 | 64.9% | $1.13 Billion | $1.73 Billion | $608.50 Million | ▲ +16.2 pp |
| 2019 | 48.8% | $636.90 Million | $1.31 Billion | $669.10 Million | ▲ +0.4 pp |
| 2018 | 48.4% | $480.76 Million | $993.15 Million | $512.39 Million | ▲ +2.9 pp |
| 2017 | 45.5% | $372.14 Million | $817.59 Million | $445.45 Million | ▼ -40.7 pp |
| 2016 | 86.2% | $314.88 Million | $365.09 Million | $50.21 Million | ▼ -3.2 pp |
| 2015 | 89.4% | $424.45 Million | $474.79 Million | $50.33 Million | ▲ +3.5 pp |
| 2014 | 85.9% | $208.70 Million | $243.03 Million | $34.33 Million | ▲ +8.0 pp |
| 2013 | 77.8% | $120.41 Million | $154.68 Million | $34.27 Million | ▼ -0.9 pp |
| 2012 | 78.8% | $154.37 Million | $195.98 Million | $41.61 Million | ▲ +35.3 pp |
| 2011 | 43.4% | $60.08 Million | $138.37 Million | $78.29 Million | ▲ +30.0 pp |
| 2010 | 13.4% | $19.34 Million | $144.42 Million | $125.08 Million | ▲ +7.8 pp |
| 2009 | 5.6% | $3.95 Million | $70.82 Million | $66.86 Million | ▼ -25.5 pp |
| 2008 | 31.1% | $36.77 Million | $118.18 Million | $81.41 Million | ▼ -11.8 pp |
| 2007 | 42.9% | $118.70 Million | $276.65 Million | $157.96 Million | ▼ -37.9 pp |
| 2006 | 80.8% | $314.72 Million | $389.68 Million | $74.96 Million | ▲ +0.0 pp |
| 2005 | 80.7% | $390.10 Million | $483.12 Million | $93.02 Million | ▲ +4.9 pp |
| 2004 | 75.9% | $393.83 Million | $519.22 Million | $125.39 Million | ▲ +5.4 pp |
| 2003 | 70.5% | $391.12 Million | $554.96 Million | $163.84 Million | ▼ -13.7 pp |
| 2002 | 84.1% | $224.25 Million | $266.54 Million | $42.28 Million | ▼ -5.5 pp |
| 2001 | 89.6% | $310.39 Million | $346.35 Million | $35.96 Million | ▲ +1.9 pp |
| 2000 | 87.8% | $163.21 Million | $185.96 Million | $22.75 Million | ▼ -0.5 pp |
| 1999 | 88.3% | $96.40 Million | $109.20 Million | $12.80 Million | ▼ -1.2 pp |
| 1998 | 89.4% | $72.00 Million | $80.50 Million | $8.50 Million | ▼ -1.1 pp |
| 1997 | 90.5% | $83.20 Million | $91.90 Million | $8.70 Million | ▼ -2.8 pp |
| 1996 | 93.3% | $72.80 Million | $78.00 Million | $5.20 Million | — |